International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial — Nobuhiro Ikemura (2024) | RDL Network
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial
Renato D. Lópes, Karen P. Alexander, Susanna R. Stevens, Harmony R. Reynolds, Gregg W. Stone, Ileana L. Piña, Frank W. Rockhold, Ahmed Elghamaz, José López‐Sendón, Pedro Sílvio Farsky, Alexander Chernyavskiy, Ariel Díaz, Denis Phaneuf, Mark de Belder, Yi‐Tong Ma, Luis A. Guzmán, Michel G. Khouri, Alessandro Sionís, Derek J. Hausenloy, Rolf Doerr, Joseph B. Selvanayagam, Aldo Maggioni, Judith S. Hochman, David J. Maron
Nobuhiro Ikemura, John A. Spertus, Dan Nguyen, Zhuxuan Fu, Philip Jones, Harmony R. Reynolds, Sripal Bangalore, Balram Bhargava, Roxy Senior, Ahmed Elghamaz, Shaun G. Goodman, Renato D. Lópes, Radoslaw M. Pracon, José López‐Sendón, Aldo Maggioni, Harvey D. White, Kreton Mavromatis, William E. Boden, Fátima Rodríguez, Judith S. Hochman, David J. Maron
Jonathan Newman, Rebecca Anthopolos, G.B. John Mancini, Sripal Bangalore, Harmony R. Reynolds, Dennis Kunichoff, Roxy Senior, Jesús Peteiro, Balram Bhargava, Pallav Garg, Jorge Escobedo, Rolf Doerr, Tomasz Mazurek, José Ramón González‐Juanatey, Grzegorz Gajos, Carlo Briguori, Hong Cheng, András Vértes, Sandeep Mahajan, Luis A. Guzmán, Matyàs Keltai, Aldo Maggioni, Gregg W. Stone, Jeffrey S. Berger, Yves Rosenberg,
Mathieu Kernéis, Megan K. Yee, Roxana Mehran, Tarek Nafee, Christoph Bode, Jonathan L. Halperin, Eric D. Peterson, Freek W.A. Verheugt, Peter Wildgoose, Martin van Eickels, Professor Gregory Lip, Marc Cohen, Keith A.A. Fox, C. Michael Gibson
Kelley R. Branch, Jeffrey L. Probstfield, John W. Eikelboom, Jackie Bosch, Aldo Maggioni, Richard K. Cheng, Deepak L. Bhatt, Álvaro Avezum, Keith A.A. Fox, Stuart J. Connolly, Olga Shestakovska, Salim Yusuf
Discussion(0)
No comments yet. Be the first to comment.